NCT00001774
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +22 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
Clinical trial condition
Cerebral Small Vessel Diseases
Explore clinical trials studying Cerebral Small Vessel Diseases. Study availability and eligibility vary by location and protocol.
282 public trials
64 recruiting studies
Cerebral Small Vessel Diseases trial results
NCT00048906
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
NCT00005111
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +20 more
- Locations
-
- National Institute of Neurological Disorders and Stroke (NINDS) Bethesda, Maryland, United States
NCT00307593
- Conditions
- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, Brain Diseases, +27 more
- Locations
-
- Hôpital Cochin Paris, France
Completed
Neuropathic Pain and Fabry Disease
NCT00168974
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- Danish Pain Research Center, Aarhus University Hospital Aarhus, Denmark
Completed
Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
NCT00430105
- Conditions
- ANCA Associated Systemic Vasculitis, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Autoimmune Diseases, +19 more
- Locations
-
Not specified
Active, Not Recruiting
Safety, Tolerability and Efficacy of NPI-001 in Patients With Hereditary Cystatin C Amyloid Angiopathy (HCCAA)
NCT07716865
- Conditions
- Amyloidosis, Amyloidosis, Familial, Brain Diseases, +29 more
- Locations
-
- Landspitali University Hospital Reykjavik, Iceland
Active, Not Recruiting
An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)
NCT06961344
- Conditions
- Acid-Base Imbalance, Acidosis, Acidosis, Lactic, +23 more
- Locations
-
- UC San Diego - Altman Clinical and Translational Research Institute La Jolla, California, United States
- Children's Hospital of Colorado Aurora, Colorado, United States
- Rare Disease Research Atlanta, Georgia, United States
- Massachusetts General Hospital Boston, Massachusetts, United States
Active, Not Recruiting
A Study to Evaluate Migalastat in Fabry Subjects With Amenable GLA Variant and Renal Disease
NCT04020055
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +32 more
- Locations
-
- Emory University Atlanta, Georgia, United States
- The Cleveland Clinic Cleveland, Ohio, United States
- Lysosomal and Rare Disorders Research and Treatment Center, Inc Fairfax, Virginia, United States
- Royal Melbourne Hospital Parkville, Victoria, Australia
Active, Not Recruiting
A Study to Evaluate the Long-term Safety and Tolerability of Lucerastat in Adult Subjects With Fabry Disease
NCT03737214
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +19 more
- Locations
-
- University of Alabama at Birmingham - Nephrology Research Clinic Birmingham, Alabama, United States
- University of California Irvine Irvine, California, United States
- UCSF Benioff Children's Hospital Oakland Oakland, California, United States
- University of Florida Clinical and Translational Science Institute, UF Clinical Research Center Gainesville, Florida, United States